Medical research published by medRxiv supports the statement, but it has also disclosed that the research is yet to be evaluated by various experts.
As per the article published by South China Morning Post on 17 March 2020, researchers said that the study was preliminary and it needed more work. They also urged the governments and medical facilities to consider blood type differences when planning mitigation measures or treating patients with the virus.
Since the research is yet to be evaluated and peer-reviewed as of 18 March 2020, the information regarding this is subjected to change.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.